Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 2, 2013)
-
-
PR Newswire (Mar 29, 2013)
-
PR Newswire (Mar 14, 2013)
-
PR Newswire (Mar 7, 2013)
-
-
PR Newswire (Feb 27, 2013)
-
-
-
-
-
Stock Watch Wednesday, 12 DecemberVFC's Stock House • Wed, Dec 12, 2012
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
Oncothyreon: Consider Buying Dips but Beware of VolatilityVFC's Stock House • Wed, Jul 27, 2011
-
-
-
-
-
-
Oncothyreon's Run Indicates the Stock Is Rising Above the RadarVFC's Stock House • Wed, May 18, 2011
-
-
-
-
-
-
-
-
Stock Watch Wednesday, 12 DecemberVFC's Stock House • Wed, Dec 12, 2012
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Weekly Stock Watch, Week Of July 1VFC's Stock House • Mon, Jul 2, 2012
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (Mar 29, 2013)
-
PR Newswire (Mar 14, 2013)
-
PR Newswire (Mar 7, 2013)
-
PR Newswire (Feb 27, 2013)
-
at MarketWatch.com (Dec 19, 2012)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Oct 31, 2012)
-
PR Newswire (Sep 5, 2012)
-
PR Newswire (Aug 29, 2012)
-
PR Newswire (Aug 9, 2012)
-
PR Newswire (Aug 8, 2012)
-
PR Newswire (Aug 8, 2012)
-
PR Newswire (Jul 24, 2012)
-
PR Newswire (Jul 5, 2012)
-
PR Newswire (Jun 21, 2012)
ONTY vs. ETF Alternatives
Company Description
Oncothyreon, Inc. is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer. Our goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives... More
